Biomarker and Intervention Development for Childhood-Onset Mental Disorders Branch
The Biomarker and Intervention Development for Childhood-Onset Mental Disorders Branch supports research leading to the development of novel, mechanism-based treatments, and preventive interventions for childhood-onset mental disorders. The programs within this branch support research to develop novel cognitive, behavioral, psychosocial, pharmacological, and device-based interventions. The branch also supports the identification of reliable and valid biomarkers useful for stratification of research participants in clinical trials or for use as objective predictors or indicators of treatment response (surrogate endpoints). The development of novel technologies, analytic strategies, and other resources for the characterization of individuals for the purposes of stratification into clinical trials, personalizing treatment, and monitoring response to treatment are of interest, particularly approaches that quantify cognitive, emotional, sensorimotor, and biobehavioral processes that are often shared across diagnostic categories.
The Autism Research Program is also administered within this branch, and supports a wide range of research on the characterization, pathophysiology, treatment, and outcomes of individuals with autism spectrum disorder and related neurodevelopmental disorders.
Acting Branch Chief
Lisa Gilotty, Ph.D.
6001 Executive Boulevard, Room 7221